Working with Glasgow-based biotech company Mironid and colleagues in the US, the Sheffield researchers have carried out successful laboratory tests of a compound developed by Mironid to treat ADPKD, a hereditary, progressive disease which affects over 60,000 people in the UK and around 12 million people worldwide.

Drug-resistant tuberculosis (DR TB) occurs when the bacteria Mycobacterium tuberculosis which causes tuberculosis becomes resistant to the drug(s) normally used to cure tuberculosis. DR TB also spreads through air, in the same way as drug-susceptible TB. It is very important to diagnose and treat drug-resistant TB, as it can be debilitating and cause death

LEAVE A REPLY

Please enter your comment!
Please enter your name here